700
Participants
Start Date
October 31, 1999
Primary Completion Date
July 31, 2001
Study Completion Date
July 31, 2001
dolasetron mesylate
granisetron hydrochloride
ondansetron
tropisetron
quality-of-life assessment
University of Rochester Cancer Center, Rochester
Hackensack University Medical Center, Hackensack
National Cancer Institute (NCI)
NIH
Gary Morrow
OTHER